Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)

Final results from the long-term Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) found low rates of hepatitis C virus (HCV) recurrence after direct-acting antiviral therapy in both HCV/human immunodeficiency virus (HIV)–coinfected (0.67/100 person-years) and HCV-infected (0.2/100 person-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyles, David L, Kang, Minhee, Matining, Roy M, Murphy, Robert L, Peters, Marion G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677564/
https://www.ncbi.nlm.nih.gov/pubmed/34926713
http://dx.doi.org/10.1093/ofid/ofab511
_version_ 1784616166505840640
author Wyles, David L
Kang, Minhee
Matining, Roy M
Murphy, Robert L
Peters, Marion G
author_facet Wyles, David L
Kang, Minhee
Matining, Roy M
Murphy, Robert L
Peters, Marion G
author_sort Wyles, David L
collection PubMed
description Final results from the long-term Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) found low rates of hepatitis C virus (HCV) recurrence after direct-acting antiviral therapy in both HCV/human immunodeficiency virus (HIV)–coinfected (0.67/100 person-years) and HCV-infected (0.2/100 person-years) groups with >500 person-years of follow-up. Confirmed reinfections were in participants with HIV who reported high-risk behaviors.
format Online
Article
Text
id pubmed-8677564
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-86775642021-12-17 Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) Wyles, David L Kang, Minhee Matining, Roy M Murphy, Robert L Peters, Marion G Open Forum Infect Dis Brief Reports Final results from the long-term Viral Hepatitis C Infection Long-term Cohort Study (V-HICS) found low rates of hepatitis C virus (HCV) recurrence after direct-acting antiviral therapy in both HCV/human immunodeficiency virus (HIV)–coinfected (0.67/100 person-years) and HCV-infected (0.2/100 person-years) groups with >500 person-years of follow-up. Confirmed reinfections were in participants with HIV who reported high-risk behaviors. Oxford University Press 2021-10-14 /pmc/articles/PMC8677564/ /pubmed/34926713 http://dx.doi.org/10.1093/ofid/ofab511 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Brief Reports
Wyles, David L
Kang, Minhee
Matining, Roy M
Murphy, Robert L
Peters, Marion G
Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
title Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
title_full Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
title_fullStr Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
title_full_unstemmed Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
title_short Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)
title_sort continued low rates of hepatitis c virus (hcv) recurrence in hcv/hiv- and hcv-infected participants who achieved sustained virologic response after direct-acting antiviral treatment: final results from the aids clinical trials group a5320 viral hepatitis c infection long-term cohort study (v-hics)
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677564/
https://www.ncbi.nlm.nih.gov/pubmed/34926713
http://dx.doi.org/10.1093/ofid/ofab511
work_keys_str_mv AT wylesdavidl continuedlowratesofhepatitiscvirushcvrecurrenceinhcvhivandhcvinfectedparticipantswhoachievedsustainedvirologicresponseafterdirectactingantiviraltreatmentfinalresultsfromtheaidsclinicaltrialsgroupa5320viralhepatitiscinfectionlongtermcohortstudyvhics
AT kangminhee continuedlowratesofhepatitiscvirushcvrecurrenceinhcvhivandhcvinfectedparticipantswhoachievedsustainedvirologicresponseafterdirectactingantiviraltreatmentfinalresultsfromtheaidsclinicaltrialsgroupa5320viralhepatitiscinfectionlongtermcohortstudyvhics
AT matiningroym continuedlowratesofhepatitiscvirushcvrecurrenceinhcvhivandhcvinfectedparticipantswhoachievedsustainedvirologicresponseafterdirectactingantiviraltreatmentfinalresultsfromtheaidsclinicaltrialsgroupa5320viralhepatitiscinfectionlongtermcohortstudyvhics
AT murphyrobertl continuedlowratesofhepatitiscvirushcvrecurrenceinhcvhivandhcvinfectedparticipantswhoachievedsustainedvirologicresponseafterdirectactingantiviraltreatmentfinalresultsfromtheaidsclinicaltrialsgroupa5320viralhepatitiscinfectionlongtermcohortstudyvhics
AT petersmariong continuedlowratesofhepatitiscvirushcvrecurrenceinhcvhivandhcvinfectedparticipantswhoachievedsustainedvirologicresponseafterdirectactingantiviraltreatmentfinalresultsfromtheaidsclinicaltrialsgroupa5320viralhepatitiscinfectionlongtermcohortstudyvhics

Ejemplares similares